Cargando…
PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort
PTEN deletion is an established prognostic biomarker in prostate cancer. We compared PTEN immunohistochemistry (IHC) and PTEN fluorescence in situ hybridization (FISH) in the largest existing radical prostatectomy cohort with clinical follow-up data. There was high concordance between IHC and FISH:...
Autores principales: | Lotan, Tamara L., Heumann, Asmus, Rico, Sebastian Dwertmann, Hicks, Jessica, Lecksell, Kristen, Koop, Christina, Sauter, Guido, Schlomm, Thorsten, Simon, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630353/ https://www.ncbi.nlm.nih.gov/pubmed/29029453 http://dx.doi.org/10.18632/oncotarget.19217 |
Ejemplares similares
-
Analytic Validation of a Clinical-Grade PTEN Immunohistochemistry Assay in Prostate Cancer by Comparison to PTEN FISH
por: Lotan, Tamara L., et al.
Publicado: (2016) -
PTEN Loss is Associated with Upgrading of Prostate Cancer from Biopsy to Radical Prostatectomy
por: Lotan, Tamara L., et al.
Publicado: (2014) -
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers
por: Burdelski, Christoph, et al.
Publicado: (2015) -
The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer
por: Turnham, Daniel J., et al.
Publicado: (2020) -
Catalysis by the Tumor-Suppressor Enzymes PTEN and PTEN-L
por: Johnston, Sean B., et al.
Publicado: (2015)